blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4061355

EP4061355 - ANTI-INFLAMMATORY COMPOUNDS FOR USE IN THE TREATMENT OF DERMAL DISORDERS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  26.08.2022
Database last updated on 02.11.2024
FormerThe international publication has been made
Status updated on  29.05.2021
Formerunknown
Status updated on  11.12.2020
Most recent event   Tooltip27.11.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Council of Scientific & Industrial Research
Anusandhan Bhawan
2 Rafi Marg
New Delhi 110001 / IN
[2022/39]
Inventor(s)01 / KOTAMRAJU, Srigiridhar
Applied Biology, CSIR-IICT
Hyderabad Telangana 500007 / IN
02 / BATHULA, Surendar Reddy
Genetic Chemistry Laboratory, CSIR-IICT
Hyderabad Telangana 500007 / IN
03 / SISTLA, Ramakrishna
Applied Biology, CSIR-IICT
Hyderabad Telangana 500007 / IN
04 / ADDLAGATTA, Anthony
Applied Biology, CSIR-IICT
Hyderabad Telangana 500007 / IN
05 / THENNATI, Rajamannar
Sun Pharma Advanced Research Centre, Sun Pharma
Road, Nima Compound
Vadodara Gujarat 390012 / IN
06 / SHAIKH, Altab
Genetic Chemistry Laboratory, CSIR-IICT
Hyderabad Telangana 500007 / IN
07 / JANGUM, Aruna
Applied Biology, CSIR-IICT
Hyderabad Telangana 500007 / IN
08 / SANGARAJU, Rajendra
Applied Biology, CSIR-IICT
Hyderabad Telangana 500007 / IN
09 / NEELI, Praveen Kumar
Applied Biology, CSIR-IICT
Hyderabad Telangana 500007 / IN
10 / MADHUSUDANA, Kuncha
Applied Biology, CSIR-IICT
Hyderabad Telangana 500007 / IN
11 / GAJALAKSHMI, Singuru
c/o Genetic Chemistry Laboratory
CSIR-IICT
Hyderabad Telangana 500 007 / IN
 [2022/39]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2022/39]
Application number, filing date20817077.923.11.2020
[2022/39]
WO2020IB61043
Priority number, dateIN20191104790622.11.2019         Original published format: IN201911047906
[2022/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021100027
Date:27.05.2021
Language:EN
[2021/21]
Type: A1 Application with search report 
No.:EP4061355
Date:28.09.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 27.05.2021 takes the place of the publication of the European patent application.
[2022/39]
Search report(s)International search report - published on:EP27.05.2021
ClassificationIPC:A61K31/37, A61P17/02, A61P17/06
[2022/39]
CPC:
A61K31/37 (EP); A61K31/665 (US); A61K9/0014 (US);
A61P17/02 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/39]
TitleGerman:ENTZÜNDUNGSHEMMENDE VERBINDUNGEN ZUR VERWENDUNG BEI DER BEHANDLUNG VON DERMALEN STÖRUNGEN[2022/39]
English:ANTI-INFLAMMATORY COMPOUNDS FOR USE IN THE TREATMENT OF DERMAL DISORDERS[2022/39]
French:COMPOSÉS ANTI-INFLAMMATOIRES DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT D'AFFECTIONS DE LA PEAU[2022/39]
Entry into regional phase21.06.2022National basic fee paid 
21.06.2022Designation fee(s) paid 
21.06.2022Examination fee paid 
Examination procedure21.06.2022Amendment by applicant (claims and/or description)
21.06.2022Examination requested  [2022/39]
21.06.2022Date on which the examining division has become responsible
Fees paidRenewal fee
28.11.2022Renewal fee patent year 03
27.11.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]EP0694305  (INDENA SPA [IT]) [Y] 23-29* claims 1,4 *;
 [X]US2016244470  (SRIGIRIDHAR KOTAMRAJU [IN], et al) [X] 27-29 * claims 1-3 *;
 [Y]  - JEONG N ET AL, "Inhibitory effect of esculetin on atopic dermatitis-like skin lesions", FEBS JOURNAL, & 42ND CONGRESS OF THE FEDERATION-OF-EUROPEAN-BIOCHEMICAL-SOCIETIES (FEBS) ON FROM MOLECULES TO CELLS AND BACK; JERUSALEM, ISRAEL; SEPTEMBER 10 -14, 2017, (201709), vol. 284, no. Suppl. 1, Sp. Iss. SI, page 125, XP002801993 [Y] 1-29 * abstract *
 [Y]  - CHEN YUCHAO ET AL, "Esculetin Ameliorates Psoriasis-Like Skin Disease in Mice by Inducing CD4<+>Foxp3<+>Regulatory T Cells.", FRONTIERS IN IMMUNOLOGY 2018, (2018), vol. 9, ISSN 1664-3224, page 2092, XP002801994 [Y] 1-29 * the whole document *

DOI:   http://dx.doi.org/10.3389/fimmu.2018.02092
 [Y]  - YAMADA M ET AL, "8(S)-hydroxyeicosatetraenoic acid is the lipoxygenase metabolite of arachidonic acid that regulates epithelial cell migration in the rat cornea.", CORNEA MAY 2000, (200005), vol. 19, no. 3 Suppl, ISSN 0277-3740, pages S13 - S20, XP002801995 [Y] 1-29 * abstract *
by applicantUS9580452
    - EGAN et al., Drug Metab. Rev., (19900000), vol. 22, pages 503 - 529
    - LIN et al., Arch. Toxicol., (20000000), vol. 74, pages 467 - 72
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.